Drug combination could overcome tumour resistance in paediatric cancers
Children with some solid tumours may benefit from receiving a combination of inhibitor drugs, according to interim results of research presented at the American Association of Cancer Research’s Annua…
West Midlands Innovation Accelerator to Spark Growth and Innovation
The Universities of Birmingham and Aston – both BHP members – are to participate in the West Midlands Innovation Accelerator announced this week by the West Midlands Combined Authority.Designed to bo…
Learning from the pandemic: Birmingham Health Partners publishes rapid evaluation study of remote outpatient appointments
Birmingham Health Partners (BHP), the second city’s University-NHS partnership, has called for greater engagement with clinicians and a deeper understanding of patient experience when considering the…
New drug can lower brain pressure and treat blinding IIH headaches, finds trial
Patients with Idiopathic Intercranial Hypertension (IIH) – a condition which causes raised brain pressure and debilitating headaches – could be treated with an injectable peptide used for type 2 diab…
Funding boost for Birmingham rare disease research
BHP founder-member the University of Birmingham has been awarded a £500k Pathfinder Award from the medical research charity LifeArc which will support early-stage projects with a focus on translation…
BHP invests £300k in innovative service improvement projects
Birmingham Health Partners (BHP), the second city’s University-NHS partnership, has announced the inaugural recipients of its Seed Fund programme, awarding more than £300,000 to four projects across…